EGFR TKIs: Efficacy, Combinations, & Use After Chemotherapy – 2022 Program: Targeted Therapies Forum

Dive deep into the world of EGFR TKIs with Dr. Millie Das and Angel Qin in this enlightening session from the 2022 Targeted Therapies Forum. Explore the efficacy of EGFR TKIs, their potential combinations, and their strategic use post-chemotherapy to optimize treatment outcomes in cancer patients.

A heartfelt acknowledgment to our generous sponsors: #Novartis, #Janssen, #Blueprintmedicine, #TakedaOncology, #Astrazeneca, #LillyOncology, and #genentech for their unwavering support in advancing cancer research and patient care.

Equip yourself with the latest advancements in cancer therapy. Explore further at http://cancerGRACE.org/. Join our dedicated community and be part of the conversation at https://cancergrace.org/forum.